Skip to main navigation Skip to main content

On demand webinar

Understanding cannabidiol: current evidence, availability and access pathways Members login for free access About RACGP online events

Details

Type: On-demand
Recorded: 24 Feb 2021

Contact

For more information:
Email: RACGP NSW&ACT Events
Call: 02 9886 4707

Price

RACGP Members: FREE
Non-Members: FREE

Watch now

Understanding cannabidiol: current evidence, availability and access pathways

On-demand recorded 24 Feb 2021

The RACGP NSW&ACT has partnered with the NSW Ministry of Health on this webinar about recent developments in relation to cannabidiol, including registration of Epidyolex®, and their implications for practice. The webinar will also provide an overview of the evidence for the use of cannabidiol in treatment of certain conditions and the appropriate circumstances for compounding cannabis based medicines.

Learning outcomes

  1. Describe the evidence for the use of cannabidiol in Lennox-Gastaut syndrome, Dravet syndrome and Tuberous Sclerosis Complex, and the approved indication for Epidyolex®
  2. Describe the evidence for the use of cannabidiol, and where off-label use of Epidyolex® might have sufficient evidence
  3. Describe appropriate circumstances for compounding of medicines, and specifically for cannabis based medicines
  4. Describe the evidence for and role of cannabis based medicines in management of pain
This event attracts 2 CPD points

This event attracts 2 CPD points

Facilitator

Dr Tim Senior
MBBS, FRACGP

Tim is a GP at Tharawal Aboriginal Corporation in South Western Sydney.

Presenters

Judith Mackson
Chief Pharmacist and Director Chief Pharmacist Unit NSW Ministry of Health

Dr Jan Fizzell
Medical Advisor, NSW Ministry of Health

Professor Andrew McLachlan
Head of School and Dean of Pharmacy in the Sydney Pharmacy School at the University of Sydney

Advertising

© 2021 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807